Discover the detailed record of transactions filed by Beraud Jill, Director. Insider active across 2 companies, notably Revance Therapeutics, Inc.. Cumulatively, 14 reports have been published. The latest transaction was disclosed on 24 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Jill Beraud is a Board Member at Revance Therapeutics, Inc. and Levi Strauss & Co. In this role, she contributes to the governance and strategy of the companies. Jill is recognized for her expertise in management and business development, enabling her to provide strategic advice to discussions within the boards. Her varied experience in the industry allows her to provide valuable perspectives to support innovation.